Company
Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| LY5830966 | Phase 1 | Primary Myelofibrosis |
Latest
No recent events.
Follow Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.